| Trial ID: | L3547 |
| Source ID: | NCT04517201
|
| Associated Drug: |
Incdss Based Insulin Regime
|
| Title: |
AI-Assisted Insulin Titration System on Inpatients Glucose Control
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: iNCDSS based insulin regime|DRUG: Physician based insulin regime
|
| Outcome Measures: |
Primary: Fasting plasma glucose of T2D patients, Fasting plasma glucose of T2D patients by self-monitoring of bloodglucose (SMBG) in both groups, After 7-day intervention | Secondary: Well-controlled rate of fasting blood glucose, The well-controlled rate of blood glucose is defined as proportion of the time of sensor glucose measurements in targeted range, During 7-day intervention|Incidence of hypoglycemia, The hypoglycemia is defined as blood glucose level less than 3.9mmol/L., During 7-day intervention|Total insulin dose, The total insulin dose is defined as daily insulin dose., During 7-day intervention
|
| Sponsor/Collaborators: |
Sponsor: Shanghai Zhongshan Hospital
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
120
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2020-11-04
|
| Completion Date: |
2021-12
|
| Results First Posted: |
|
| Last Update Posted: |
2021-03-23
|
| Locations: |
Zhongshan Hospital, Shanghai, Shanghai, 200032, China|Zhongshan Hospital, Fudan University, Shanghai, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04517201
|
